4.6 Article

Plasma Cytokines/Chemokines as Predictive Biomarkers for Lymphedema in Breast Cancer Patients

Related references

Note: Only part of the references are listed.
Article Oncology

Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging

Melissa B. Aldrich et al.

Summary: This study investigated the use of near-infrared fluorescence lymphatic imaging (NIRF-LI) surveillance to predict early onset of peripheral lymphatic dysfunction as a predictor of breast cancer-related lymphedema (BCRL). The results showed that dermal backflow can predict the development of BCRL months before arm swelling occurs, enabling early treatment to prevent edema and irreversible tissue changes.

BREAST CANCER RESEARCH AND TREATMENT (2022)

Article Oncology

Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer-Related Lymphedema

Giacomo Montagna et al.

Summary: The study evaluated the rates of BCRL and associated risk factors in women treated with ALND, highlighting that Black race, Hispanic ethnicity, older age, NAC receipt, and longer follow-up were independently associated with an increased risk of BCRL. Further research is needed to explore the biological mechanisms behind racial and ethnic disparities in BCRL development.

JAMA ONCOLOGY (2022)

Article Oncology

The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements

Chirag Shah et al.

Summary: This meta-analysis aimed to evaluate the impact of monitoring techniques on the incidence of chronic breast cancer-related lymphedema (BCRL), and found that using bioimpedance spectroscopy significantly reduces the relative risk of chronic BCRL by 69% and 81% compared to background and circumference monitoring, respectively.

BREAST CANCER RESEARCH AND TREATMENT (2021)

Article Medicine, General & Internal

Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women

Leila Dorling et al.

Summary: This study sequenced samples from 60,466 women with breast cancer and 53,461 controls using a panel of 34 putative susceptibility genes, identifying associations between protein-truncating variants in certain genes and breast cancer risk. The results provide important information for genetic counseling and define genes that are most clinically useful for predicting breast cancer risk.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Oncology

The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment

Mads G. Jorgensen et al.

Summary: This study found that patients with BCRL had significantly poorer HRQoL compared to those without BCRL in 16 out of 18 HRQoL subscales over a period of up to 10 years. Age, BMI, BCRL severity, hand and dominant arm affection had minor impact on HRQoL, suggesting a high degree of inter-individual variation in coping with lymphedema.

NPJ BREAST CANCER (2021)

Review Biochemistry & Molecular Biology

The Lymphatic Vasculature in the 21st Century: Novel Functional Roles in Homeostasis and Disease

Guillermo Oliver et al.

Review Oncology

Psychosocial Issues Associated with Breast Cancer-Related Lymphedema: a Literature Review

L. H. Eaton et al.

CURRENT BREAST CANCER REPORTS (2020)

Review Immunology

The Interplay Between Lymphatic Vessels and Chemokines

Rae H. Farnsworth et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Immunology

The role of interleukin-1 in general pathology

Naoe Kaneko et al.

INFLAMMATION AND REGENERATION (2019)

Article Oncology

Survivorship and Advocacy in Inflammatory Breast Cancer

Angela Alexander et al.

JOURNAL OF CANCER (2018)

Review Biochemistry & Molecular Biology

Inflammatory Manifestations of Lymphedema

Catherine L. Ly et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Multidisciplinary Sciences

Topical tacrolimus for the treatment of secondary lymphedema

Jason C. Gardenier et al.

NATURE COMMUNICATIONS (2017)

Review Surgery

Lymphedema: From diagnosis to treatment

Oguz Kayiran et al.

TURKISH JOURNAL OF SURGERY (2017)

Article Oncology

Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management

Mei R. Fu

WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)

Article Biochemistry & Molecular Biology

Cytokines are systemic effectors of lymphatic function in acute inflammation

Melissa B. Aldrich et al.

CYTOKINE (2013)

Article Oncology

STANDARDIZED METHOD FOR QUANTIFICATION OF DEVELOPING LYMPHEDEMA IN PATIENTS TREATED FOR BREAST CANCER

Marek Ancukiewicz et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)

Article Immunology

Inflammatory cytokines IL-6 and TNF-α regulate lymphocyte trafficking through the local lymph node

Janet L. -K. Wee et al.

VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2011)

Article Oncology

Human Lymphatic Architecture and Dynamic Transport Imaged Using Near-infrared Fluorescence

John C. Rasmussen et al.

TRANSLATIONAL ONCOLOGY (2010)

Article Immunology

Interleukin-1β modulates proinflammatory cytokine production in human epithelial cells

Mehmet A. Eskan et al.

INFECTION AND IMMUNITY (2008)